Clinical Trials Directory

Trials / Completed

CompletedNCT00848198

TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease

A Prospective Study to Establish Normative Values, Demographic Variations, Referent Diagnostic Values and Disease Severity Correlations for Dry Eye Disease and TearLab Osmometry.

Status
Completed
Phase
Study type
Observational
Enrollment
314 (actual)
Sponsor
TearLab Corporation · Industry
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Accepted

Summary

This is a prospective, observational case series to determine the clinical utility of tear osmolarity and other commonly used objective tests to diagnose dry eye disease, as well as to establish referent values for objective tests of the disease.

Detailed description

This is a prospective, observational case series to determine the clinical utility of tear osmolarity, tear film breakup time, corneal fluorescein staining, conjunctival lissamine green staining, Schirmer's test without anesthesia, Bron/Foulks meibomian glan grading and the ocular surface disease index to diagnose dry eye disease, as well as to establish referent values for objective tests of the disease. Patients were recruited across sites in the EU and US from the general clinical population.

Conditions

Timeline

Start date
2009-02-01
Primary completion
2011-03-01
Completion
2011-03-01
First posted
2009-02-20
Last updated
2016-05-16
Results posted
2016-04-14

Locations

10 sites across 5 countries: United States, France, Germany, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT00848198. Inclusion in this directory is not an endorsement.

TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease (NCT00848198) · Clinical Trials Directory